KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Incyte (INCY) Other Operating Expenses (2016 - 2026)

Incyte filings provide 17 years of Other Operating Expenses readings, the most recent being $127.6 million for Q1 2026.

  • For the quarter ending Q1 2026, Other Operating Expenses rose 50.51% year-over-year to $127.6 million, compared with a TTM value of $369.8 million through Mar 2026, up 336.31%, and an annual FY2025 reading of $242.3 million, changed N/A over the prior year.
  • Other Operating Expenses hit $127.6 million in Q1 2026 for Incyte, down from $242.3 million in the prior quarter.
  • The five-year high for Other Operating Expenses was $242.3 million in Q2 2025, with the low at $34.5 million in Q3 2022.
  • Median Other Operating Expenses over the past 5 years was $68.9 million (2023), compared with a mean of $86.1 million.
  • The sharpest move saw Other Operating Expenses crashed 33.64% in 2022, then surged 76.2% in 2023.
  • Year by year, Other Operating Expenses stood at $82.4 million in 2022, then rose by 13.24% to $93.3 million in 2023, then crashed by 36.28% to $59.5 million in 2024, then surged by 307.32% to $242.3 million in 2025, then tumbled by 47.34% to $127.6 million in 2026.
  • According to Business Quant data, Other Operating Expenses over the past three periods came in at $127.6 million, $242.3 million, and $84.8 million for Q1 2026, Q2 2025, and Q1 2025 respectively.